País: Estats Units
Idioma: anglès
Font: NLM (National Library of Medicine)
HYDROXOCOBALAMIN ACETATE (UNII: S535M27N3Q) (HYDROXOCOBALAMIN - UNII:Q40X8H422O)
Actavis Pharma, Inc.
HYDROXOCOBALAMIN ACETATE
HYDROXOCOBALAMIN 1000 ug in 1 mL
INTRAMUSCULAR
PRESCRIPTION DRUG
- Pernicious anemia, both uncomplicated and accompanied by nervous system involvement. Pernicious anemia, both uncomplicated and accompanied by nervous system involvement. - Dietary deficiency of Vitamin B12 , occurring in strict vegetarians and in their breast-fed infants. (Isolated vitamin B12 deficiency is very rare). Dietary deficiency of Vitamin B12 , occurring in strict vegetarians and in their breast-fed infants. (Isolated vitamin B12 deficiency is very rare). - Malabsorption of vitamin B12 , resulting from structural or functional damage to the stomach, where intrinsic factor is secreted or to the ileum, where intrinsic factor facilitates vitamin B12 absorption. These conditions include tropical sprue, and nontropical sprue (idiopathic steatorrhea, gluten-induced enteropathy). Folate deficiency in these patients is usually more severe than vitamin B12 deficiency. Malabsorption of vitamin B12 , resulting from structural or functional damage to the stomach, where intrinsic factor is secreted or to the ileum, where intrinsic factor facilitates vitamin B12 absorption. These conditions include tropical sprue, and nontropical sprue (idiopathic steatorrhea, gluten-induced enteropathy). Folate deficiency in these patients is usually more severe than vitamin B12 deficiency. - Inadequate secretion of intrinsic factor, resulting from lesions that destroy the gastric mucosa (ingestion of corrosives, extensive neoplasia), and a number of conditions associated with a variable degree of gastric atrophy (such as multiple sclerosis, certain endocrine disorders, iron deficiency, and subtotal gastrectomy). Total gastrectomy always produces vitamin B12 deficiency. Structural lesions leading to vitamin B12 deficiency include regional ileitis, ileal resections, malignancies, etc. Inadequate secretion of intrinsic factor, resulting from lesions that destroy the gastric mucosa (ingestion of corrosives, extensive neoplasia), and a number of conditions associated with a variable degree of gastric atrophy (such as multiple sclerosis, certain endocrine disorders, iron deficiency, and subtotal gastrectomy). Total gastrectomy always produces vitamin B12 deficiency. Structural lesions leading to vitamin B12 deficiency include regional ileitis, ileal resections, malignancies, etc. - Competition for Vitamin B12 by intestinal parasites or bacteria. The fish tapeworm (Diphyllobothrium latum) absorbs huge quantities of vitamin B12 and infested patients often have associated gastric atrophy. The blind-loop syndrome may produce deficiency of Vitamin B12 or folate. Competition for Vitamin B12 by intestinal parasites or bacteria. The fish tapeworm (Diphyllobothrium latum) absorbs huge quantities of vitamin B12 and infested patients often have associated gastric atrophy. The blind-loop syndrome may produce deficiency of Vitamin B12 or folate. - Inadequate utilization of vitamin B12 . This may occur if antimetabolites for the vitamin are employed in the treatment of neoplasia. Inadequate utilization of vitamin B12 . This may occur if antimetabolites for the vitamin are employed in the treatment of neoplasia. - For the Schilling Test. For the Schilling Test.
Hydroxocobalamin Injection USP, 1000 mcg/mL is available in a 30 mL multiple dose vial, individually boxed. Store at 20°-25°C (68°-77°F). [See USP controlled room temperature.] PROTECT FROM LIGHT. Literature revised: January 2017 Manufactured by: Hikma Farmaceutica (Portugal) S.A. 2705-906 Terrugem SNT, Portugal Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA PIN229-WAT/2
Abbreviated New Drug Application
HYDROXOCOBALAMIN- HYDROXOCOBALAMIN INJECTION, SOLUTION ACTAVIS PHARMA, INC. ---------- HYDROXOCOBALAMIN INJECTION USP RX ONLY DESCRIPTION Hydroxocobalamin injection is a sterile solution of hydroxocobalamin for intramuscular administration. Each mL contains: Hydroxocobalamin Acetate equivalent to 1000 mcg Hydroxocobalamin, Sodium Acetate Anhydrous 0.2 mg, Glacial Acetic Acid 0.442 mg, Sodium Chloride 8.2 mg, with Methylparaben 1.5 mg and Propylparaben 0.2 mg as preservatives, in Water for Injection q.s. Additional Glacial Acetic Acid and/or Sodium Acetate may have been used to adjust pH. pH range is 3.5 to 5.0. Hydroxocobalamin appears as dark red orthorhombic needles or as an amorphous or crystalline red powder. It is very hygroscopic in the anhydrous form, and moderately soluble in water. It has a molecular weight of 1346.37. The vitamin B coenzymes are very unstable in light. Hydroxocobalamin shares the cobalamin molecular structure with cyanocobalamin. The chemical name is α-(5,6-dimethylbenzimidazoly) hydroxocobamide. The empirical formula is C H CoN O P and its structural formula is: The cobalt content is 4.34%. CLINICAL PHARMACOLOGY Vitamin B is essential to growth, cell reproduction, hematopoiesis, nucleoprotein and myelin synthesis. Fifty percent of the administered dose of hydroxocobalamin disappears from the injection site in 2.5 hours. Hydroxocobalamin is bound to plasma proteins and stored in the liver. It is excreted in the bile and undergoes some enterohepatic recycling. Within 72 hours after injection of 500 to 1000 mcg of hydroxocobalamin, 16 to 66 percent of the injected dose may appear in the urine. The major portion is excreted within the first 24 hours. 12 62 89 13 15 12 INDICATIONS AND USAGE I. Pernicious anemia, both uncomplicated and accompanied by nervous system involvement. II. Dietary deficiency of Vitamin B , occurring in strict vegetarians and in their breast-fed infants. (Isolated vitamin B deficiency is very rare). III. Malabsorption of vitamin B , resulting from structural or func Llegiu el document complet